107 filings
8-K
CTMX
CytomX Therapeutics Inc
22 Mar 24
Departure of Directors or Certain Officers
4:06pm
8-K
CTMX
CytomX Therapeutics Inc
11 Mar 24
CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update
4:02pm
8-K
CTMX
CytomX Therapeutics Inc
7 Nov 23
CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
4:05pm
8-K
CTMX
CytomX Therapeutics Inc
24 Aug 23
Entry into a Material Definitive Agreement
4:05pm
8-K
CTMX
CytomX Therapeutics Inc
8 Aug 23
CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
4:08pm
8-K
879xbi
30 Jun 23
Entry into a Material Definitive Agreement
7:07pm
8-K
5nu2 jkhjugui4
20 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
4friuq1 yiaf
9 May 23
CytomX Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:12pm
8-K
sy8cu3 wbzis73f
27 Mar 23
CytomX Therapeutics Reports Full Year 2022 Financial Results
4:13pm
8-K
whv0v l51
10 Mar 23
Regulation FD Disclosure
3:36pm
8-K
jc57br1tkt rexh13o9g
24 Feb 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
7:00am
8-K
qevnl 49q4og4xp
5 Jan 23
Entry into a Material Definitive Agreement
4:13pm
8-K
q92dp0y phhdrot
21 Nov 22
Entry into a Material Definitive Agreement
8:05pm
8-K
h6h qdbvs99c9
8 Nov 22
CytomX Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
4:09pm
8-K
qtt9iu
23 Sep 22
Departure of Directors or Certain Officers
4:07pm
8-K
rv38gk
13 Sep 22
Departure of Directors or Certain Officers
4:11pm
8-K
op8ft3ce f8
4 Aug 22
CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
4:12pm
8-K
0d3lxw3
13 Jul 22
Cost Associated with Exit or Disposal Activities
4:10pm
8-K
cp9434m887digg
6 Jul 22
Other Events
4:10pm
8-K
vmx9lnueh bnnxp9f
21 Jun 22
Submission of Matters to a Vote of Security Holders
4:16pm